New Delhi: A multicentre clinical trial has found that daily use of a standardised Ashwagandha root extract for 24 weeks was well tolerated, with no evidence of treatment-related liver or kidney injury. Published in Frontiers in Medicine on August 20, 2026, the randomised, double-blind study involved 1,200 adults across seven centres in India. Participants received Read More…
